These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 925045)

  • 1. Assay of cholera vaccine potency.
    Mumford JA; Ford AW; Richer PR
    J Biol Stand; 1977; 5(4):351-67. PubMed ID: 925045
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of potency of inactivated cholera vaccine by mouse protection assay & antibody induction method.
    Sood A; Sokhey J; Sharma SB; Gairola S; Singh S; Singh H
    Indian J Med Res; 1994 Dec; 100():262-5. PubMed ID: 7829163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Standardization of cholera vaccine and preparation of a national reference standard].
    Nenkov P; Manakhilov R; Polikar A; Karacholeva M; Genova Iu
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):55-8. PubMed ID: 6485669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prospects for improving chemical cholera vaccines].
    Markov EIu; Maramovich AS; Golubinskiĭ EP; Urbanovich LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):91-6. PubMed ID: 9783412
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent progress in cholera vaccination.
    Pierre PG; Lucas G; Van Damme M; Vaerman JP
    Acta Gastroenterol Belg; 1992; 55(5-6):430-6. PubMed ID: 1288041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The population composition of cultures of Vibrio cholerae strain 569 B Pakistan in relation to the manufacture of a cholera vaccine (choleragen-anatoxin+O-antigen)].
    Lobanov VV; Nechetskaia RM; Adamova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):73-6. PubMed ID: 2461623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae.
    Attridge SR; Rowley D
    J Infect Dis; 1983 Nov; 148(5):931-9. PubMed ID: 6195273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The protective and immunodepressive activity of cell fractions of a cholera-like vibrio].
    Stanislavskiĭ ES; Vvedenskaia OI
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):108-10. PubMed ID: 1007718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
    García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
    Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
    [No Abstract]   [Full Text] [Related]  

  • 11. CpG DNA, liposome and refined antigen oral cholera vaccine.
    Leelawongtawon R; Somroop S; Chaisri U; Tongtawe P; Chongsa-nguan M; Kalambaheti T; Tapchaisri P; Pichyangkul S; Sakolvaree Y; Kurazono H; Hayashi H; Chaicumpa W
    Asian Pac J Allergy Immunol; 2003 Dec; 21(4):231-9. PubMed ID: 15198341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
    Cryz SJ; Fürer E; Germanier R
    Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antigenicity testing of cholera vaccines by application of hog gastric mucin and ferric ammonium citrate.
    Foó I; Zsidai F
    J Biol Stand; 1977; 5(4):341-9. PubMed ID: 925044
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation.
    Borde A; Larsson A; Holmgren J; Nygren E
    Eur J Pharm Biopharm; 2011 Nov; 79(3):508-18. PubMed ID: 21757004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination against cholera: what prospects?].
    Pierre P; Lucas G; Vaerman JP
    Ann Soc Belg Med Trop; 1988 Jun; 68(2):83-93. PubMed ID: 3071278
    [No Abstract]   [Full Text] [Related]  

  • 17. An oral cholera vaccine for travelers (Vaxchora).
    Med Lett Drugs Ther; 2016 Aug; 58(1502):113-4. PubMed ID: 27552209
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholera vaccine inactivated oral.
    Drugs R D; 1999 Sep; 2(3):193-4. PubMed ID: 10641223
    [No Abstract]   [Full Text] [Related]  

  • 19. Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model.
    Anvari S; Najar-Peerayeh S; Behmanesh M; Bakhshi B
    Hum Vaccin Immunother; 2018; 14(9):2323-2328. PubMed ID: 29852089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera].
    María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L
    Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.